Drug Sponsors

Celsion to acquire Egen

Wednesday, June 11, 2014 12:48 PM

Celsion, an oncology drug development company, and Egen, a privately held biopharmaceutical company focused on the development of nucleic acid-based therapeutics for the treatment of cancer and other difficult to treat diseases, have signed a definitive asset purchase agreement for Celsion to acquire substantially all of Egen’s assets, including its phase Ib DNA-based immunotherapy product candidate Egen-001 and its therapeutic platform technologies, TheraPlas for delivery of DNA and mRNA, TheraSilence for delivery of RNA and RAST for Cell Enabled Expression and Secretion of RNA.

More... »

Quest Diagnostics

Merck to acquire Idenix for $3.85 billion

Monday, June 9, 2014 02:01 PM

Merck has agreed to acquire Idenix Pharmaceuticals for $24.50 per share in cash, for a total value of approximately $3.85 billion. The transaction has been approved by the boards of directors of both companies.

More... »


inVentiv Health, Aprecia Pharmaceuticals partner

Monday, June 9, 2014 01:58 PM

inVentiv Health, a life science knowledge and services company, and Aprecia Pharmaceuticals, a specialty pharmaceutical company, have formed an exclusive sales and marketing alliance. This partnership will launch the Aprecia brand, as well as provide comprehensive commercialization of Aprecia's pioneering technology platform and initial pharmaceutical products.

More... »

Biotech consortium launches KPI Therapeutics

Friday, June 6, 2014 12:51 PM

Five biotech firms and private investors have announced the launch of KPI Therapeutics, with the aim of speeding advancement of novel, promising drug candidates that can improve the quality of patients’ lives.

More... »

Asana BioSciences acquires drug discovery platform from Endo

Thursday, June 5, 2014 09:30 AM

Asana BioSciences, an independent member of the Amneal Alliance of Companies, has acquired the early stage branded pharmaceutical discovery platform of Endo Pharmaceuticals, a subsidiary of Endo International.

More... »

Celerion expands to Singapore, names Chew Lan Chong executive director

Wednesday, June 4, 2014 01:25 PM

Celerion has expanded its formal business presence in Singapore, and has named Dr. Chew Lan Chong, MBBS, MRCS, MSc, executive director, medical research, of its new operations. Chong has 10 years of direct operational experience leading clinical pharmacology units.

More... »

Teva to acquire Labrys Biologics for $825 million

Wednesday, June 4, 2014 12:57 PM

Teva Pharmaceutical Industries will acquire Labrys Biologics, a privately held development stage biotechnology company focused on treatments for chronic migraine and episodic migraine, broadening Teva’s array of biotechnology assets and capabilities.

More... »

Provence Technologies acquires Synprosis, rebrands as Provepep

Tuesday, June 3, 2014 09:22 AM

Provence Technologies Group, a specialist fine chemistry research group, has acquired Synprosis, a France-based company specializing in the chemical synthesis of peptides and proteins for therapeutic use. The financial terms of the agreement have not been disclosed.

More... »

Adaptimmune, GlaxoSmithKline collaborate on cancer therapies

Tuesday, June 3, 2014 08:05 AM

Adaptimmune, a biotechnology company developing TCR engineered T-cells to treat cancer, has entered into a strategic collaboration and licensing agreement with GlaxoSmithKline (GSK) for the development and commercialization of its lead clinical cancer program.

More... »

Roche acquires Genia Technologies to strengthen next generation sequencing pipeline

Monday, June 2, 2014 01:09 PM

Roche has acquired Genia Technologies, a privately held, California-based company. Genia is developing a single-molecule, semiconductor-based, DNA sequencing platform using nanopore technology.

More... »

CWWeekly

April 20

Christie Clinic, PMG Research's 12th clinical research site, expands its geographic reach north to Illinois

Clinipace acquires Accovion to expand European presence, following an infusion of equity that could lead to more deals

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs